نتائج البحث

|IUPACName=2-Hydroxybenzenecarbohydroxamic acid | InChI = 1/C7H7NO3/c9-6-4-2-1-3-5(6)7(10)8-11/h1-4,9,11H,(H,8,10)

<tt><nowiki>== مستوى 2 ==</nowiki></tt><br /> == مستوى 2 ==

| InChI = 1/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3/t17-/m1 | StdInChI = 1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3/t17-/m1

...(2''S'')-2-{[(2''S'')-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | elimination_half-life = 2 hours

...6''E'')-7-[4-(4-fluorophenyl)-2-(''N''-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid | InChI = 1/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26

| IUPAC_name = 4-chloro-2-(furan-2-ylmethylamino)- 5-sulfamoylbenzoic acid | InChI = 1/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)

| [[عناصر الدورة الثانية|'''2''']] ...]]) وهذه العناصر تتميز بوجود 5 إلكترونات في غلاف الطاقة الخارجي لها، ويوجد 2 إلكترون في المستوى الفرعي s، و3 إلكترونات

...hloro-''N''¹-methyl-''N''¹-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide | C=13 | H=19 | Cl=1 | N=2 | O=5 | S=2

*البالغون: 2-6 غ/يوم كجرعة مفردة أو مقسمة على 2-4 جرعات، يمكن إعطاء 12 غ/يوم بالطريق الوريد 100-150 ملغ/كغ/يوم (50 ملغ/كغ لدى حديثي الولادة) مقسمة على 2-4 جرعات

...ame = (''E'')-[1-(2,4-dichlorophenyl)-2-(1''H''-imidazol-1-yl)ethylidene][(2,4-dichlorophenyl)methoxy]amine | InChI = 1/C18H13Cl4N3O/c19-13-2-1-12(16(21)7-13)10-26-24-18(9-25-6-5-23-11-25)15-4-3-14(20)8-17(15)22/h1-8,

...E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl [1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetate

| InChI = 1/C32H38N2O8/c1-37-24-12-17(13-25(38-2)29(24)39-3)31(35)42-26-14-18-16-34-11-10-20-19-8-6-7-9-22(19)33-28(20)23(34 | StdInChI = 1S/C32H38N2O8/c1-37-24-12-17(13-25(38-2)29(24)39-3)31(35)42-26-14-18-16-34-11-10-20-19-8-6-7-9-22(19)33-28(20)23(34

| IUPAC_name = 1-[(''Z'')-2-[2-(4-chlorophenoxy)ethoxy]-2-(2,4-dichlorophenyl)-1-methylvinyl]-1''H''-imidazole | C=l3 | H=17 | N=2 | O=2

...i>'</nowiki>'',''N<nowiki>'</nowiki>''-dimethyl-''N''-pyridin-2-ylethane-1,2-diamine | InChI = 1/C17H23N3O/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15/h4-11H,12-14H2,1-3H3

...ydroxy-dioxostiborane; (2''R'',3''R'',4''R'',5''S'')-6-methylaminohexane-1,2,3,4,5-pentol | StdInChI = 1S/C7H17NO5.H2O.2O.Sb/c1-8-2-4(10)6(12)7(13)5(11)3-9;;;;/h4-13H,2-3H2,1H3;1H2;;;/q;;;;+1/p-1/t4-,5+,6+,7+;;;;/m0..../s1

...0^2,6]dodecan-4-yl]- 6-methyl- 6,11-diazatetracyclo [7.6.1.0^2,7.0^12,16] hexadeca- 1(16),9,12,14-tetraene- 4-carboxamide | smiles = O=C3N1CCC[C@H]1[C@]2(O)O[C@](C(=O)N2[C@H]3CC(C)C)(NC(=O)[C@@H]6C[C@@H]7c4cccc5c4c(cn5)C[C@H]7N(C

...4-(1-Methylpiperidin-4-ylidene)-4,9-dihydro-10''H''-benzo[4,5]cyclohepta[1,2-''b'']thiophen-10-one | StdInChI = 1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3

طبق المرهم على الجفن السفلي للعين المصابة 2- 4 مرات يوميأ.

<math>\mathcal {}x^2+2x+1=0</math> <math>\mathcal {}x^2+2x+1=(x+1)^2=(x+1)(x+1)=0</math>

| IUPAC_name = (''RS'')-1-{2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1''H''-imidazole | C=18 | H=15 | Cl=3 | N=2 | O=1

| IUPAC_name = sodium 2-sulfanylethanesulfonate | C=2 | H=5 | Na=1 | O=3 | S=2

| IUPAC_name = N-(2-hydroxyethyl)-3-phenyl-2-propenamide | CAS_number = 6961-46-2

| PIN = 2-Ethyl-3-hydroxy-4''H''-pyran-4-one ...herNames = 2-Ethyl-3-hydroxy-4-pyranone<br />2-Ethyl pyromeconic acid<br />2-Ethyl-3-hydroxy-4-pyrone

| IUPAC_name = 1-(1-{2-[(3-chlorophenyl)methoxy]phenyl}ethenyl)-1''H''-imidazole | C=18 | H=15 | Cl=1 | N=2 | O=1

<td>[[فلز قلوى ترابي|'''2''']]</td> <td bgcolor="#c0ffff"><font color="green">2</font><br />[[هيليوم|He]]</td>

| IUPAC_name = 3-(1-benzyl-4-piperidyl)-3-phenylpiperidine-2,6-dione | CAS_number = 21888-98-2

...-[(2-hydroxyethyl)(methyl)amino]-1,3,7-trimethyl-3,7-dihydro-1''H''-purine-2,6-dione | synonyms = Methylcoffanolamine; 8-(2-hydroxyethyl)methylaminocaffeine

| IUPAC_name = 2-[(''E'')-2-(2,5-Dimethyl-1-phenylpyrrol-3-yl)ethenyl]-''N'',''N'',1-trimethylquinolin-1-i | InChI = 1/C26H28N3/c1-19-17-21(20(2)29(19)24-9-7-6-8-10-24)11-13-23-14-12-22-18-25(27(3)4)15-16-26(22)28(23)5/h

...ame = (3''R'')-3-(4-chlorophenyl)-4-[&#8203;[&#8203;[(1''S'')-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy]carbonyl]amino]butanoic acid | InChI=1S/C19H26ClNO6/c1-11(2)17(24)26-18(12(3)4)27-19(25)21-10-14(9-16(22)23)13-5-7-15(20)8-6-13/h5-8,11

...'',8''R'',8a''R'')-6-hydroxy-2-methyl-8-{[(2''S'')-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-heptanoic acid | elimination_half-life = 1.5-2 hours

| StdInChI = 1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4 ...droxy-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-''d''][1,3]dioxol-6(5a''H'')-one

| IUPAC_name = ''N''-(1-adamantyl)-2-[2-(dimethylamino)ethoxy]acetamide | C=16 | H=28 | N=2 | O=2

| IUPACName = Calcium 1,3-dihydroxypropan-2-yl phosphate | CASNo = 27214-00-2

...H''-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate | elimination_half-life = 2 hours for simvastatin and 1.9 hours for simvastatin acid

| IUPAC_name = 3-(4-chlorophenyl)-5-morpholin-4-yl-4''H''-imidazol-2-one | C=13 | H=14 | Cl=1 | N=3 | O=2

| InChI = 1/C20H38O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22-4-2/h11-12H,3-10,13-19H2,1-2H3/b12-11- ...nChI = 1S/C20H38O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22-4-2/h11-12H,3-10,13-19H2,1-2H3/b12-11-

*هضمي: غثيان 5%، إسهال 2%، نزف هضمي 2%. *دموية: نقص بيض 3%، فقر دم 2%.

| IUPAC_name = [(3''R'')-3-(prop-2-ynylamino)indan-5-yl]-''N''-propylcarbamate | C=16 | H=20 | N=2 | O=2

...)<br />-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy<br />-5-(hydroxymethyl)oxolan-2-yl]oxy<br />-3-hydroxycyclohexyl]oxyoxane-3,4-diol | InChI = 1/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(

...(''RS'')-1-(''tert''-butylamino)-3-[(2-methyl-1''H''-indol-4-yl)oxy]propan-2-yl benzoate | C=23 | H=28 | N=2 | O=3

| C=1 | H=4 | Cl=2 | O=6 | P=2 ...ثيره بالظهور خلال 24-48 ساعة من إعطائه ويصل لذروته بعد 5-7 أيام ويدوم لمدة 2-3 أسابيع , يطرح مع البول دون تبدل.

...3,5-diethyl 4-{2-[(1''E'')-3-(''tert''-butoxy)-3-oxoprop-1-en-1-yl]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate *للبالغين: الجرعة الأولية: 2 ملغ مرة واحدة/يوم، يُفض في الصباح.

| IUPAC_name = (''RS'')-''N''-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide | C=12 | H=20 | N=2 | O=3 | S=1

| StdInChI = 1S/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13) | InChI = 1/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13)

...-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione | CAS_number = 54-42-2

..._name = (±)-(2''R*'',6''S*'')-2,6-dimethyl-4-{2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl}morpholine | InChI = 1/C21H35NO/c1-7-21(5,6)20-10-8-19(9-11-20)12-16(2)13-22-14-17(3)23-18(4)15-22/h8-11,16-18H,7,12-15H2,1-6H3/t16?,17-,18+

...ر (5) وضعيات. وعندها سيشير المؤشر إلى الوضعية (0101) التي تساوي (5) ولطرح (2) من (3) نمسح المسجل أولا ثم نقدم المؤشر ثلا

| InChI = 1S/2Na.H2O4S/c;;1-5(2,3)4/h;;(H2,1,2,3,4)/q2*+1;/p-2 | InChI1 = 1S/2Na.H2O4S/c;;1-5(2,3)4/h;;(H2,1,2,3,4)/q2*+1;/p-2

...mes=(''R'')-''N''- [(5-Chloro- 3,4-dihydro- 8-hydroxy- 3-methyl- 1-oxo- 1H-2-benzopyran-7-yl) -carbonyl]- ''L''- phenylalanine<br>(-)-''N''- [(5-Chloro- ...1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1

...rihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-2-(''tert''-butylamino)acetamide | InChI = 1/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)2

| IUPAC_name = ethane-1,2-diylbis[(methylimino)propane-3,1-diyl] bis(3,4,5-trimethoxybenzoate) | C=30 | H=44 | N=2 | O=10

...-<br />3-amino-6-[(1''R'')-<br />1-(methylamino)ethyl]oxan-2-yl]oxy}-<br />2-hydroxycyclohexyl]oxy}-5-methyl-<br />4-(methylamino)oxane-3,5-diol | elimination_half-life = 2 hrs

...me = ''N''-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5-dihydro-1''H''-imidazol-2-amine

...onta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | InChI = 1/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20

...hI = 1/C18H37N.FH/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19;/h9-10H,2-8,11-19H2,1H3;1H/b10-9+; ...I = 1S/C18H37N.FH/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19;/h9-10H,2-8,11-19H2,1H3;1H/b10-9+;

2- شرجياُ:

...12a''R'')-decahydro-3,6,9-trimethyl-3,12-epoxy-12''H''-pyrano[4,3-''j'']-1,2-benzodioxepin-10-ol | InChI = 1/C15H24O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-13,16H,4-7H2,1-3H3/t8-,9-

| InChI = 1/C19H29N3O/c1-5-22(6-2)12-8-9-15(3)21-18-14-17(23-4)13-16-10-7-11-20-19(16)18/h7,10-11,13-15,21H,5 | StdInChI = 1S/C19H29N3O/c1-5-22(6-2)12-8-9-15(3)21-18-14-17(23-4)13-16-10-7-11-20-19(16)18/h7,10-11,13-15,21H,5

...c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/m11./s1 ...c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/m11./s1

...للوقاية من لزوجة المفرزات المخاطية التنفسية، وبعدها يعطى بجرعة 100-200 ملغ 2-3 مرات كل يوم.

| IUPACName= 2-[3-[(4-Amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-5-yl] ethanol | StdInChI = 1S/C12H17N4OS.ClH/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13;/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15);1H/q+1;/p-1

| IUPAC_name = 5-chloro-2-hydroxy-3-(2-thienylcarbonyl)-1''H''-indole-1-carboxamide | C=14 | H=9 | Cl=1 | N=2 | O=3 | S=1

...mino-3- [4-amino-3,5-dihydroxy-6-(hydroxymethyl) tetrahydropyran-2-yl]oxy- 2-hydroxy- cyclohexoxy]- tetrahydropyran- 3,4,5-triol | elimination_half-life = 2 hours 30 minutes

| InChI = 1/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2 | StdInChI = 1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2

...(3''R'',5''S'',6''E'')-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1''H''-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid | elimination_half-life = 2.5 hours

...-(2,3-dihydro-1''H''-inden-2-yl)-2-{[(2''S'')-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanamido]acetic acid | chemical_formula = C₂₆H₃₂N₂O₅

| IUPAC_name = O5-methyl O3-[(3''R'')-1-(phenylmethyl)piperidin-3-yl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate ...I = 1/C28H31N3O6/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(19(2)29-18)28(33)37-23-13-8-14-30(17-23)16-20-9-5-4-6-10-20/h4-7,9-12,15,23,26,2

...,16,17-octahydro-6''H''-cyclopenta[''a'']phenanthren-17-yl)-2-oxo-ethyl] 2,2-dimethylpropanoate | smiles = O=C(OCC(=O)[C@@H]3[C@]2(C[C@H](O)[C@]4(Cl)[C@@]/1(\C(=C/C(=O)\C=C\1)[C@@H](F)C[C@H]4[C@@H]2C[C@H]3C

| IUPAC_name = 1-(2-chlorophenyl)-3-dimethylamino-<br>1-phenyl-propan-1-ol | InChI = 1/C17H20ClNO/c1-19(2)13-12-17(20,14-8-4-3-5-9-14)15-10-6-7-11-16(15)18/h3-11,20H,12-13H2,1-2H3

| elimination_half-life = 1.5 to 4h (mean 2.5) ...23NO7/c1-23-8-7-11-9-14-20(29-10-28-14)21(27-4)15(11)17(23)18-12-5-6-13(25-2)19(26-3)16(12)22(24)30-18/h5-6,9,17-18H,7-8,10H2,1-4H3/t17-,18+/m1/s1

| IUPAC_name = 3-Allyl-5-isobutyl-2-thioxo-4-imidazolidinone | C=10 | H=16 | N=2 | O=1 | S=1

...'3-(butanoyloxymethyl) ''O''5-methyl&nbsp;(4''R'')- 4-(2,3-dichlorophenyl)-2,6-dimethyl- 1,4-dihydropyridine-3,5-dicarboxylate | C=21 | H=23 | Cl=2 | N=1 | O=6

...PAC_name = (+)-(2''S'',3''S'')-2-(3-chlorophenyl)-3,5,5-trimethylmorpholin-2-ol | C=13 | H=18 | Cl=1 | N=1 | O=2

| SystematicName = 1,3,4,5,6-Pentahydroxyhex-2-one | InChI = 1/C6H12O6/c7-1-3-4(9)5(10)6(11,2-8)12-3/h3-5,7-11H,1-2H2/t3-,4-,5+,6-/m1/s1

| IUPAC_name = 7-(4-methylpiperazin-1-yl)-3''H''-1,3-benzoxazol-2-one | C=12 | H=15 | N=3 | O=2

...(''RS'')-5-[3-(''tert''-butylamino)-2-hydroxypropoxy]-3,4-dihydroquinolin-2(1''H'')-one | C=16 | H=24 | N=2 | O=3

C 14 H 15 N 5 O 6 S 2

| IUPAC_name = 2-(2,2-dicyclohexylethyl)piperidine | CAS_number = 6621-47-2

...name = (''RS'')-5-[2-(3,4-Dimethoxyphenyl)ethyl-methylamino]-2-propan-2-yl-2-(3,4,5-trimethoxyphenyl)pentanenitrile | InChI = 1/C28H40N2O5/c1-20(2)28(19-29,22-17-25(33-6)27(35-8)26(18-22)34-7)13-9-14-30(3)15-12-21-10-11-23

|IUPACName=6-hydroxy-1,3-benzoxathiol-2-one

| C=8 | H=10 | N=2 | O=3 | S=1 | InChI = 1/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11)

| [[عناصر الدورة الثانية|'''2''']] ...فصيلة [[تشكيل إلكتروني|بالتشكيل الإلكتروني]] الخارجي nsp²np²، مع العلم بأن المدار d¹⁰ يوجد في ا

| InChI = 1/C11H12N4O3S/c1-18-11-10(13-6-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15) | StdInChI = 1S/C11H12N4O3S/c1-18-11-10(13-6-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15)

http://www.indianjsurg.com/text.asp?2007/69/2/43/32190 Am Fam Physician. 2002 Jan 15;65(2):251-8. Available:

...name = 4-[(3''Z'',5''E'')-3,5-bis(6-oxo-1-cyclohexa-2,4-<br>dienylidene)-1,2,4-triazolidin-1-yl]benzoic acid | InChI = 1/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,22-23H,(H,27,28)/b

| IUPAC_name = (''RS'')-2-{4-[(2,3-Dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine | InChI = 1/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h

| CAS_number = 50-44-2 | InChI = 1/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)

...yl]-3-hydroxynaphthalene-2-carboxylic acid; 1-methyl-2-[(''E'')-2-thiophen-2-ylethenyl]-5,6-dihydro-4''H''-pyrimidine</small> ...-13-8-3-7-12-11(13)6-5-10-4-2-9-14-10/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2,4-6,9H,3,7-8H2,1H3/b;6-5+

| IUPAC_name = 3-(2,6-Dichlorophenyl)-2-ethyl-4-quinazolinone | C=16 | H=12 | Cl=2 | N=2 | O=1

| IUPAC_name = 2-[4-(diphenylmethyl)piperazin-1-yl]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate ...I=1S/C35H38N4O6/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-

| IUPAC_name = 3-(3''R'')-1-benzylpyrrolidin-3-yl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate ...= 1S/C27H29N3O6/c1-17-23(26(31)35-3)25(20-10-7-11-21(14-20)30(33)34)24(18(2)28-17)27(32)36-22-12-13-29(16-22)15-19-8-5-4-6-9-19/h4-11,14,22,25,28H,12-1

...'R'',2''R'',4''S'',7''S'',9''S'')-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^2,4]non-7-yl ester ...= 1/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1

| IUPAC_name = 3-methyl 5-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | InChI = 1/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/

| IUPACName = (2''S'')-2-[(4-{[(2-amino-4-hydroxypteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic aci | OtherNames = ''N''-&#x200b;(4-&#x200b;{[(2-&#x200b;amino-&#x200b;4-&#x200b;oxo-&#x200b;1,&#x200b;4-&#x200b;dihydropter

...ca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy}-2,4-dimethyl-4-propoxyoxan-3-yl butanoate | InChI = 1/C42H69NO15/c1-11-16-32(48)55-40-27(6)53-34(23-42(40,7)58-31(47)12-2)56-37-26(5)54-41(36(50)35(37)43(8)9)57-38-28(19-20-44)21-24(3)29(45)18-15-1

| IUPAC_name = [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate | InChI = 1/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)

| IUPAC_name = 2-[(3''S'')-3-{[(2''S'')-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}- | C=24 | H=28 | N=2 | O=5

| IUPAC_name = (''RS'')-Dimethyl (2,2,2-trichloro-1-hydroxyethyl)phosphonate | InChI = 1/C4H8Cl3O4P/c1-10-12(9,11-2)3(8)4(5,6)7/h3,8H,1-2H3

| IUPAC_name = (''RS'')-2-(''tert''-butylamino)-1-(2-chlorophenyl)ethanol | InChI = 1/C12H18ClNO/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13/h4-7,11,14-15H,8H2,1-3H3

| IUPACName = 2-Hydroxy-''N'',''N'',''N''-trimethylethanaminium | OtherNames = Bilineurine, (2-Hydroxyethyl)trimethylammonium

| IUPAC_name = (''RS'')-benzyl ''N''-[3-(acetylthio)-2-benzylpropanoyl]glycinate | InChI = 1/C21H23NO4S/c1-16(23)27-15-19(12-17-8-4-2-5-9-17)21(25)22-13-20(24)26-14-18-10-6-3-7-11-18/h2-11,19H,12-15H2,1H3,(H,2

...me = (''RS'')-''N'',''N''-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide | C=7 | H=15 | Cl=2 | N=2 | O=2 | P=1

...)-1-(''tert''-butylamino)-3-(3,4-dihydro-2''H''-thiochromen-8-yloxy)propan-2-ol | C=16 | H=25 | N=1 | O=2 | S=1

| ImageNameL1 = Stereo structural formula of glucosamine ((2S,6R)-6-meth,-2-ol) | ImageNameR1 = Ball and stick model of glucosamine ((2R,6R)-6-meth,-2-ol)

...8-11-5-6-12-18,17-9-3-1-4-10-17)13-16-20-14-7-2-8-15-20/h1,3-4,9-10,18,21H,2,5-8,11-16H2

| IUPAC_name = 2-(2-diethylaminoethoxy)ethyl 2-ethyl-2-phenyl-butanoate | InChI = 1/C20H33NO3/c1-5-20(6-2,18-12-10-9-11-13-18)19(22)24-17-16-23-15-14-21(7-3)8-4/h9-13H,5-8,14-17H2,1

| IUPAC_name = 2-(Hexadecyloxy)-6-methyl-4''H''-3,1-benzoxazin-4-one ...1S/C25H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-28-25-26-23-18-17-21(2)20-22(23)24(27)29-25/h17-18,20H,3-16,19H2,1-2H3

| PIN = 3-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]propanoic acid | SystematicName = 3-(2,4-Dihydroxy-3,3-dimethylbutanamido)propanoic acid<ref>{{cite web|title=pant

| IUPAC_name = 2,4-dibromo-6-{[cyclohexyl(methyl)amino]methyl}aniline | C=14 | H=20 | Br=2 | N=2

...')-1-{4-[(2-isopropoxyethoxy)methyl]phenoxy}-<br/>3-(isopropylamino)propan-2-ol | InChI = 1/C18H31NO4/c1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4/h5-8,14-15,17,19-20

| IUPAC_name = 1,3-bis(2-ethylhexyl)-5-methylhexahydropyrimidin-5-amine .../C22H46N2/c1-7-11-13-20(9-3)15-23-17-22(5,6)18-24(19-23)16-21(10-4)14-12-8-2/h20-21H,7-19H2,1-6H3

| IUPAC_name = 2-(2-diethylaminoethoxy)ethyl 2-phenylbutanoate | InChI = 1/C18H29NO3/c1-4-17(16-10-8-7-9-11-16)18(20)22-15-14-21-13-12-19(5-2)6-3/h7-11,17H,4-6,12-15H2,1-3H3

2. محاليل باليتش Palitzch:

| InChI = 1/C11H12N4O3S/c1-18-11-10(13-6-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15) | StdInChI = 1S/C11H12N4O3S/c1-18-11-10(13-6-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15)

...,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoate | smiles = [Ca+2].[O-]C(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[O-]C(=O)[C@H](O)[C@@H](O)[C@

...,4''E'',6''E'',8''E'')-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraen-1-ol | InChI1 = 1/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H

...-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-''a'']pyridin-3(2''H'')-one ...19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2

| IUPAC_name = (''RS'')-[4-(1-Hydroxy-2-''tert''-butylamino-ethyl)- 2-(4-methylbenzoyl)oxy-phenyl] 4-methylbenzoate ...-18)26(31)33-24-15-14-22(23(30)17-29-28(3,4)5)16-25(24)34-27(32)21-12-8-19(2)9-13-21/h6-16,23,29-30H,17H2,1-5H3

=== 2- مسكنات للألم ومضادات ضعيفة للالتهاب مثل:

| IUPACName = Propan-2-yl hexadecanoate | InChI = 1/C19H38O2/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19(20)21-18(2)3/h18H,4-17H2,1-3H3

...tramethoxy-15,15,30,30-tetramethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2^3,6.1^8,12.1^18,22.0^27,31.0<sup>16 | C=40 | H=48 | N=2 | O=6 | Cl=2

| IUPAC_name = (''RS'')-1-[2-(Allyloxy)phenoxy]-3-(isopropylamino)propan-2-ol ...-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3/h4-8,12-13,16-17H,1,9-11H2,2-3H3

...,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(2''H''-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1''H''-imidazole-5-carboxylate | InChI = 1/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-

| IUPAC_name = (''RS'')-''N''²-benzoyl-''N'',''N''-dipropyl-α-glutamine | C=18 | H=26 | N=2 | O=4

| ImageFile = 2-tert-Butyl-4-hydroxyanisole_and_3-tert-butyl-4-hydroxyanisole_2D.svg | PIN = 2-''tert''-Butyl-4-methoxyphenol and 3-''tert''-butyl-4-methoxyphenol (mixtur

| C=15 | H=26 | N=2 | StdInChI = 1S/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12-,13-,14-,15+/m0/s1

| IUPAC_name = 2-oxo-2-(3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino)ethyl acetate | C=19 | H=28 | N=2 | O=4

* المدارات الذرية التي لها n = 2 يطلق عليها الغلاف L . :<math> E_n = \frac {E_1}{n^2} = \frac {-13.6eV}{n^2}, \quad n=1,2,3,\ldots </math>

| IUPAC_name = ''N''-benzyl-''N''-(3-isobutoxy-2-pyrrolidin-1-yl-propyl)aniline<!--from ChemSpider--> | C=24 | H=34 | N=2 | O=1

| InChI = 1/C11H20O2/c1-2-3-4-5-6-7-8-9-10-11(12)13/h2H,1,3-10H2,(H,12,13) | StdInChI = 1S/C11H20O2/c1-2-3-4-5-6-7-8-9-10-11(12)13/h2H,1,3-10H2,(H,12,13)

| InChI = 1/2Na.H2O3S2/c;;1-5(2,3)4/h;;(H2,1,2,3,4)/q2*+1;/p-2 | StdInChI = 1S/2Na.H2O3S2/c;;1-5(2,3)4/h;;(H2,1,2,3,4)/q2*+1;/p-2

| IUPAC_name = 2-phenyl-2-(1-phenylpropan-2-ylamino)acetonitrile | C=17 | H=18 | N=2

| IUPAC_name = ''N''-[2-(5-methoxy-1''H''-indol-3-yl)ethyl]<br/>acetamide | C=13 | H=16 | N=2 | O=2

| InChI = 1/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H | StdInChI = 1S/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H

| 2

| IUPAC_name = 1-(2-Methyl-5-nitro-1''H''-imidazol-1-yl)propan-2-ol | StdInChI = 1S/C7H11N3O3/c1-5(11)4-9-6(2)8-3-7(9)10(12)13/h3,5,11H,4H2,1-2H3

| IUPAC_name = (E)-1-(Diphenylmethyl)-4-(3-phenylprop-2-enyl)piperazine | C=26 | H=28 | N=2

| IUPAC_name = (''R'',''R'')-(+)-Methyl 2-phenyl-2-(2-piperidyl)acetate | C=14 | H=19 | N=1 | O=2

| IUPAC_name = 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1''H''-imidazole | C=14 | H=14 | N=2

...luorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1''H''-1,2,4-triazol-1-yl)butan-2-ol ...I = 1/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1

| C=22 | H=18 | N=2 .../C22H18N2/c1-3-7-18(8-4-1)19-11-13-21(14-12-19)22(24-16-15-23-17-24)20-9-5-2-6-10-20/h1-17,22H

| IUPAC_name = 5-Bromo-2-phenyl-1''H''-indene-1,3(2''H'')-dione | C=15 | H=9 | Br=1 | O=2

| IUPAC_name = ''O''-2-naphthyl methyl(3-methylphenyl)thiocarbamate | InChI = 1/C19H17NOS/c1-14-6-5-9-17(12-14)20(2)19(22)21-18-11-10-15-7-3-4-8-16(15)13-18/h3-13H,1-2H3

...6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;/h2*2-17H2,1H3,(H,19,20);/q;;+2/p-2 ...6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;/h2*2-17H2,1H3,(H,19,20);/q;;+2/p-2

| IUPAC_name = 2-Chloro-''N''-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide | metabolism = <2% metabolised by [[CYP2C9]], [[CYP3A4]], [[CYP3A5]]

| smiles = OC(=O)[C@@H]3[C@@H](O)C[C@@]2(O)C[C@@H](O)C[C@H]4O[C@@H]4/C=C/C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\[C@H](O[C@@ ...ChI = 1/C33H47NO13/c1-18-10-8-6-4-3-5-7-9-11-21(45-32-30(39)28(34)29(38)19(2)44-32)15-25-27(31(40)41)22(36)17-33(42,47-25)16-20(35)14-24-23(46-24)12-13-

| IUPAC_name = 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione | elimination_half-life = 2-3 hours<ref>http://www.rxlist.com/script/main/mobileart-rx.asp?drug=buspar&

...PAC_name = (''RS'')-1-(Isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol | InChI = 1/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3

|image name 2= |image name 2 comment=

...'-&#8203;pyran-&#8203;2-&#8203;yl]oxy}-&#8203;6-&#8203;(ethylamino)-&#8203;2-&#8203;hydroxycyclohexyl]oxy}-&#8203;5-&#8203;methyl-&#8203;4-&#8203;(methy | elimination_half-life = 2.5 hours

| IUPAC_name = (''RS'')-2-diethylamino-1-phenylpropan-1-one | InChI = 1/C13H19NO/c1-4-14(5-2)11(3)13(15)12-9-7-6-8-10-12/h6-11H,4-5H2,1-3H3

...PAC_name = (±)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[''c,f'']pyrazino[1,2-''a'']azepine | C=18 | H=20 | N=2

...l)-3- methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1''H''-purine-2,6-dione | C=25 | H=28 | N=8 | O=2

...'-(2-[(5-[(dimethylamino)methyl]furan-2-yl)methylthio]ethyl)-''N'''-methyl-2-nitroethene-1,1-diamine | elimination_half-life = 2&ndash;3 hours

| IUPAC_name = (2''E'')-2-[(5-Methoxy-1''H''-indol-3-yl)methylene]-''N''-pentylhydrazinecarboximidami | InChI = 1/C16H23N5O/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21)/b20-11+

...-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1,4-5,10-11,19,22H,2-3,6-9,12-17H2 2 ملغ

| IUPAC_name = 4-({2-butyl-5-[2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1''H''-imidazol-1-yl}methyl)benzoic acid | C=23 | H=24 | N=2 | O=4 | S=1

| IUPAC_name = 4-Diethylaminobut-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylethanoate | elimination_half-life = 12.4-13.2 hours

| IUPAC_name = 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}quinazoline-2,4(1''H'',3''H'')-dione | smiles = c1ccc2c(c1)c(=O)n(c(=O)[nH]2)CCN3CCC(CC3)C(=O)c4ccc(cc4)F

| IUPAC_name = 5-chloro-''N''-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide | C=13 | H=8 | Cl=2 | N=2 | O=4

| IUPAC_name = 2-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-<BR>10''H''-phenothiazine | InChI = 1/C20H24ClN3S/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24/h2-3,5-8,15H,4,9-14H2,1H3

| [[عناصر الدورة الثانية|'''2''']]

...-1-{4-[2-(cyclopropylmethoxy)ethyl]-<br/>phenoxy}-3-(isopropylamino)propan-2-ol | InChI = 1/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20

[[تصنيف:2-Arylpropionic acids]]

| Sb=2 | S=5 3Na2S + Sb2S5 + 9 H2O → 2 Na3SbS4 · 9H2O

{| border="2" cellpadding="4" cellspacing="0" style="margin: 1em 1em 1em 0; background: {| border="2" cellpadding="4" cellspacing="0" style="margin: 1em 1em 1em 0; background:

(6R,7R)-7-[(2R)-2-hydroxy-2-phenylacetyl)amino]-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

| OtherNames = ''trans''-1,2-Ethylenedicarboxylic acid<br />2-Butenedioic acid<br />''trans''-butenedioic acid<br />Allomaleic acid<br /> | InChI = 1/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1+

...xy-6-(hydroxymethyl)<br>-3-methylamino-tetrahydropyran-2-yl] oxy-3-hydroxy-2-methyl<br>-tetrahydrofuran-3-carbaldehyde | smiles = C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C

:<math>r_\mathrm{e}=\frac{1}{4\pi\epsilon_0}\frac{e^2}{m_e c^2} = 2.8179402894(58) \times 10^{-15} \mathrm{m}</math> :<math>r_\mathrm{e}= \frac{e^2}{m_e c^2} = 2.8179402894(58)\times 10^{-13} \mathrm{cm}</math>

| IUPAC_name = 4-hydrazinyl-1-hydrazinylidene-1,2-dihydrophthalazine | InChI = 1/C8H10N6/c9-11-7-5-3-1-2-4-6(5)8(12-10)14-13-7/h1-4H,9-10H2,(H,11,13)(H,12,14)

| IUPAC_name = 2,4:2',4'-''O''-(oxydistibylidyne)bis[<small>D</small>-gluconic acid] | C=12 | H=38 | Na=3 | O=26 | Sb=2

...7,9,13,37-heptahydroxy-17-(5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl)-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23, | C=60 | H=88 | N=2 | O=19

| CAS_number = 317-52-2 | C=36 | H=42 | Br=2 | N=2

...C_name = <nowiki>Methyl(2S-cis)-7-chloro-6,7,8-trideoxy-6[[(4-ethyl-2-piperidinyl) | C=17 | H=31 | Cl=1 | N=2 | O=5 | S=1

| IUPAC_name = (''RS'')-1-cyclopentyl-''N''-methyl-propan-2-amine | InChI = 1/C9H19N/c1-8(10-2)7-9-5-3-4-6-9/h8-10H,3-7H2,1-2H3

...أفيونات بعد انتهاء التخدير (الرضع والأطفال): 0.01 ملغ/ كغ, يمكن تكرارها كل 2- 3 دقائق حسب الاستجابة. - الوليد حتى عمر 5 سنوات: 0.1 ملغ/ كغ, تكرر كل 2- 3 دقائق حسب الحاجة, وقد يستطب تكرارها كل 20

| IUPACName = 4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol | StdInChI = 1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3

| IUPAC_name = 2-(4-butoxyphenyl)-''N''-hydroxyacetamide | InChI = 1S/C12H17NO3/c1-2-3-8-16-11-6-4-10(5-7-11)9-12(14)13-15/h4-7,15H,2-3,8-9H2,1H3,(H,13,14)

| IUPAC_name = (''RS'')-2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate ...n Journal of Clinical Pharmacology]] | year = 1990 | volume = 39 | issue = 2 | pages = 193–4 | pmid = 2253675 | doi = 10.1007/BF00280060}}</ref>

| IUPAC_name = (''RS'')-3-(2-methoxyphenoxy)propane-1,2-diol | InChI = 1/C10H14O4/c1-13-9-4-2-3-5-10(9)14-7-8(12)6-11/h2-5,8,11-12H,6-7H2,1H3

...l sulfone<br />methylsulfonylmethane<br />sulfonylbismethane<br />DMSO₂ | InChI = 1/C2H6O2S/c1-5(2,3)4/h1-2H3

| IUPAC_name = (''R'')-2-[3-(diisopropylamino)-1-phenylpropyl]-4-methylphenol | InChI = 1/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,2

| IUPAC_name = 2-[4-(benzo[1,3]dioxol-5-ylmethyl)piperazin-1-yl]pyrimidine | C=16 | H=18 | N=4 | O=2

| IUPAC_name = 4-amino-5-fluoro-1,2-dihydropyrimidin-2-one | protein_bound = 2.9 to 4%

...-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-15-[(2-methoxyethoxy)methyl]-2,6,8,10,12,17-hexamethyl-4,16-dioxa-14-azabicyclo[11.3.1]heptadecan-5-one | C=42 | H=78 | N=2 | O=14

| IUPAC_name = 2-[1-(aminomethyl)cyclohexyl]acetic acid | InChI = 1/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)

...= 2-((2''R'',6''S'')-6-((''S'')-2-Hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl)-1-phenylethanone | C=22 | H=27 | N=1 | O=2

...y-10,13-dimethyl-2,16-bis(1-methyl-3,4,5,6-tetrahydro-2''H''-pyridin-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1''H''-cyclopenta[''a'']phen | elimination_half-life = 1.5 to 2.7 hours

| IUPAC_name = 7,8-Didehydro-4,5α-epoxy-17-methyl-3-[2-(morpholin-4-yl)ethoxy]morphinan-6α-ol | C=23 | H=30 | N=2 | O=4

*عمر النصف: 3 ساعات بجرعة 2-3 ملغ/كغ. *ألم العظم المفصلي: 1-2 ملغ/كغ/يوم تضبط على أقل جرعة مؤثرة بنتائج

| IUPAC_name = 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]pyrazolidine-3,5-dione | C=23 | H=20 | N=2 | O=3 | S=1

...-4,4'-{hexane-1,6-diyl''bis''[imino(1-hydroxyethane-2,1-diyl)]}dibenzene-1,2-diol | C=22 | H=32 | N=2 | O=6

| IUPAC_name = isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | C=20 | H=24 | N=2 | O=6

| CAS_number = 58-40-2 | C=17 | H=20 | N=2 | S=1

| IUPAC_name = ''N''-ethyl-1-phenyl-propan-2-amine | StdInChI = 1S/C11H17N/c1-3-12-10(2)9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3

|IUPACName=2,5,9-trimethyl-7''H''-furo[3,2-''g'']chromen-7-one | InChI = 1/C14H12O3/c1-7-4-12(15)17-14-9(3)13-10(6-11(7)14)5-8(2)16-13/h4-6H,1-3H3

...rihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide | CAS_number = 154-21-2

...(2''S'',3''R'')-3-amino-6-(aminomethyl)-3,4-dihydro-2''H''-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol

| IUPAC_name = 4-[(7-chloro-2-methoxy-pyrido[3,2-b]quinolin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol | legal_status = CLP (EU): Acute Tox. 3(H301), Eye Dam. 1 (H318), Repr. 2 (H361), Aquatic Chronic 4 (H413)

| chemical_formula = (Na-Ca)0.33-(Al-Mg)2-Si4-O10-(O-H)2·(H2O)2

{| cellspacing="2" cellpadding="10" border="1" align="center" | align="center" | 2 || align="center" | محمية جبل عبد العزيز|| align="center"

...N''-benzyl-''N'',''N''-dimethyl-2-phenoxyethanaminium 3-hydroxynaphthalene-2-carboxylate | StdInChI = 1S/C17H22NO/c1-18(2,15-16-9-5-3-6-10-16)13-14-19-17-11-7-4-8-12-17/h3-12H,13-15H2,1-2H3/q+1

| InChI = 1/CH2O3.K/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1 | StdInChI = 1S/CH2O3.K/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1

| IUPAC_name = 1,1',1<nowiki>''</nowiki>-(2-chloroethene-1,1,2-triyl)tris(4-methoxybenzene); 11-chloro-4,13-dimethoxy-12-(''p''-methoxyphe | StdInChI = 1S/C23H21ClO3/c1-25-19-10-4-16(5-11-19)22(17-6-12-20(26-2)13-7-17)23(24)18-8-14-21(27-3)15-9-18/h4-15H,1-3H3

| IUPAC_name = 5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-4H-pyrazol-3-one | C=11 | H=11 | Cl=2 | N=3 | O=1

...6,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabino-he | CAS_number = 71751-41-2

|IUPACName=calcium 2-hydroxypropanoate |OtherNames=calcium lactate 5-hydrate,<br> calcium lactate,<br>2-hydroxypropanoic acid<br>calcium salt pentahydrate

...0-16-27)43(59)60-25(2)34(38(54)45-29)46-39(55)36-33(52)18-11-20-44-36;1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27 ...0-16-27)43(59)60-25(2)34(38(54)45-29)46-39(55)36-33(52)18-11-20-44-36;1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27

| IUPAC_name = (''RS'')-1-(1''H''-indol-4-yloxy)-3-(isopropylamino)propan-2-ol | StdInChI = 1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3

| IUPACName = (''R'')-5-(1,2-dithiolan-3-yl)pentanoic acid | InChI = 1/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/t7-/m1/s1

| IUPAC_name = 5,5-diethylpyrimidine-2,4,6(1''H'',3''H'',5''H'')-trione | elimination_half-life = 30.3 (± 3.2) hours

| IUPAC_name = 3-(4,5-dihydro-1''H''-imidazol-2-ylmethyl)- 2,4-dimethyl-6-tert-butyl-phenol | C=16 | H=24 | N=2 | O=1

| InChI = 1/C7H7ClO/c1-5-4-6(9)2-3-7(5)8/h2-4,9H,1H3 | StdInChI = 1S/C7H7ClO/c1-5-4-6(9)2-3-7(5)8/h2-4,9H,1H3

| IUPAC_name = 7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione | C=16 | H=13 | Cl=1 | N=2 | O=2

| IUPAC_name = (''RS'')-1-(1-methylethylamino)-3-(1-naphthyloxy)propan-2-ol | C=16 | H=21 | N=1 | O=2

| IUPAC_name = 5-isopropyl 3-methyl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate *الأمراض الوعائية الدماغية: 2- 4 ملغ مرتين يومياً.

*محلول للحقن :2 مغ /مل.

| IUPAC_name = 4-chloro-''N''-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoylbenzamide | elimination_half-life = 5.8 to 8.2 hours

...-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hex ...6)(H,35,43)(H,36,45)(H,37,42)(H,39,44)(H3,29,31,38)(H3,30,34,47);10-15,18H,2-9,26-28H2,1H3,(H,32,40)(H,33,45)(H,35,42)(H,36,41)(H,37,43)(H,39,44)(H3,29,

| SystematicName = 1,3,3-Trimethyl-2-[3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl] ...(3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis[2,6,6-trimethylcyclohexene]

| IUPAC_name = 2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate | InChI = 1/C24H25NO4/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25/h2,4-5,8-12H,3,6-7,13-16H2,1H3

| IUPAC_name = 9-methoxy-7''H''-furo[3,2-''g'']chromen-7-one | elimination_half-life = ~2 hours

| IUPAC_name = 2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine | elimination_half-life = 2–3 hours

| C=28 | H=28 | N=2 | O=2 | StdInChI = 1S/C28H28N2O2/c29-22-28(24-12-6-2-7-13-24,25-14-8-3-9-15-25)18-21-30-19-16-27(17-20-30,26(31)32)23-10-4-1-5-1

*يستخم في الجراحة ال[[عين]]ية كمحلول 1-2%.

|IUPACName=2-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid

...1β,16α)-9,21-dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl 2-furoate ...4</sub> for Mometasone<br> C₂₇H₃₀O₆Cl₂ as Furoate

| C=7 | H=10 | N=2 | O=2 | S=1 | StdInChI = 1S/C7H10N2O2S/c8-5-6-1-3-7(4-2-6)12(9,10)11/h1-4H,5,8H2,(H2,9,10,11)

...5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-([2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl)-1H-benzimidazole-7-carboxylate | InChI = 1/C30H24N4O8/c1-3-38-28-31-23-10-6-9-22(27(35)39-16-24-17(2)40-30(37)41-24)25(23)34(28)15-18-11-13-19(14-12-18)20-7-4-5-8-21(20)26-32-2

| EC_number = 2.4.2.8 | IUBMB_EC_number = 2/4/2/8

2- الطلاب المشاركون والمشرفون على المشروع.

| IUPAC_name = 2-diethylaminoethyl-4-amino-2-chloro-benzoate | C=13 | H=19 | Cl=1 | N=2 | O=2

...''N''-Benzyl-''N'',''N''-dimethyl-2-<nowiki/>{2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy}ethanaminium chloride | SystematicName = Benzyldimethyl(2-<nowiki/>{2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy}ethyl)azanium chloride

...-chloro-3-(dichloromethyl)-1,1-dioxo-<BR>3,4-dihydro-2''H''-benzo[''e''][1,2,4]thiadiazine-<BR>7-sulfonamide | C=8 | H=8 | Cl=3 | N=3 | O=4 | S=2

...= (5''E'',9''E'',13''E'')-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one

| InChI = 1/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1 | StdInChI = 1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1

| InChI = 1S/3Ca.2H3O4P/c;;;2*1-5(2,3)4/h;;;2*(H3,1,2,3,4)/q3*+2;;/p-6 | SMILES = [O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ca+2].[Ca+2].[Ca+2]

| IUPAC_name = 6-chloro-1,1-dioxo-2''H''-1,2,4-benzothiadiazine-7-sulfonamide | C=7 | H=6 | Cl=1 | N=3 | O=4 | S=2

| IUPAC_name = (''RS'')-1,2,3,4-Tetrahydro-2-isopropylaminomethyl-7-nitro-6-quinolylmethanol | elimination_half-life = 1 to 2.5h

| OtherNames=C18:2 ([[Fatty acid#Nomenclature|Lipid numbers]])،حمض اللينولييك ...1/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-

فيديو عدد 2

...'R'')-hydroxyethyl)-9,13,15-trimethyloxacyclooctadeca-3,5,9,13,15-pentaene-2-one | C=52 | H=74 | Cl=2 | O=18

| IUPAC_name = (3,5-dibromo-4-hydroxyphenyl)- (2-ethyl-3-benzofuranyl)methanone | StdInChI = 1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1

<td>[[فلز قلوى ترابي|'''2''']]</td>

| IUPACName = [(''2S'')-2-[(''2R'')-4,5-Dihydroxy-3-oxo-2-furyl]-2-hydroxy-ethyl] hexadecanoate ...-12-13-14-15-18(24)28-16-17(23)21-19(25)20(26)22(27)29-21/h17,21,23,25-26H,2-16H2,1H3/t17-,21+/m0/s1

| IUPAC_name = (2''S'')-2-amino- 3-(4-hydroxyphenyl)- 2-methylpropanoic acid | InChI = 1/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)/t10-/m0/s1

| IUPAC_name = (''RS'')-1-(2-(2,4-Dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl)-1''H''-imidazole | C=18 | H=14 | Cl=4 | N=2 | O=1

| IUPAC_name = 10-(2-Dimethylaminopropyl)-''N'',''N''-dimethylphenothiazine-2-sulfonamide | StdInChI = 1S/C19H25N3O2S2/c1-14(20(2)3)13-22-16-8-6-7-9-18(16)25-19-11-10-15(12-17(19)22)26(23,24)21(4)5/h6-12,1

| InChI = 1/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H | StdInChI = 1S/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H

...ومياً أو بتواتر أكبر في الحالات الشديدة, أما في حالة الإنتان الحاد قطر 1 – 2 نقطة كل 15 – 30 دقيقة ومن ثم خفض الجرعة بالت

| InChI=1/C14H10O4/c15-13(11-7-3-1-4-8-11)17-18-14(16)12-9-5-2-6-10-12/h1-10H | StdInChI = 1S/C14H10O4/c15-13(11-7-3-1-4-8-11)17-18-14(16)12-9-5-2-6-10-12/h1-10H

| IUPAC_name = Methyl [5-(propylthio)-1''H''-benzoimidazol-2-yl]carbamate | C=12 | H=15 | N=3 | O=2 | S=1

| IUPAC_name = 1-[''bis''(4-fluorophenyl)methyl]-4-[(2''E'')-3-phenylprop-2-en-1-yl]piperazine | C=26 | H=26 | F=2 | N=2

...4-methoxyphenyl)-1''H''-benzimidazol-5-yl]-5-methyl-4,5-dihydropyridazin-3(2''H'')-one | C=19 | H=18 | N=4 | O=2

| IUPAC_name = 2-(chloromethyl)oxirane 2-methyl-1H-imidazole copolymer | chemical_formula = (C₇H₁₁ClN₂O)_n

| EC_number = 2.7.1.21 | IUBMB_EC_number = 2/7/1/21

...o''-hexopyranosyl]oxy}-5,7,8,11,13,15-hexamethyl-4,10-dioxo-1,9-dioxaspiro[2.13]hexadec-6-yl acetate ...)C)[C@@H](OC)C1)C)[C@H](C(=O)O[C@H](C)[C@H](C)[C@H](OC(=O)C)[C@H](C(=O)[C@]2(OC2)C[C@@H]3C)C)C)C)C)C

| IUPAC_name = (''RS'')-1,3-dimethyl-3-phenyl-pyrrolidine-2,5-dione | elimination_half-life = 1.4–2.6 hours <small>(mesuximide)</small><br>28–38 hours <small>(active metabol

| IUPAC_name = 5-(4-chlorophenyl)-6-ethyl- 2,4-pyrimidinediamine | InChI = 1/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)

(2) ''K. ozaenae''

| smiles = O=C(SCF)[C@]3(OC(=O)CC)[C@]2(C[C@H](O)[C@]4(F)[C@@]/1(\C(=C/C(=O)\C=C\1)[C@@H](F)C[C@H]4[C@@H]2C[C@H]3C) ...21/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3;3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2/t13-,15+,16+,18+,19+,22+,23+,24+,25+;/m1./s1

| InChI = 1/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3 | StdInChI = 1S/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3

| IUPACName=2-aminoethanesulfonic acid | InChI=1/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6)

| IUPAC_name = ''N''-(4-Chlorobenzoyl)-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine | C=19 | H=15 | Cl=1 | N=2 | O=4

| IUPAC_name = [(''R''*,''S''*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol ...0(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12-,15+/m1/s1

| IUPAC_name = 2-butyl-3-({4-[2-(2''H''-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one ...17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)

...e = 9-[(2''R'',3''R'',4''S'',5''R'')-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3''H''-purin-6-one | StdInChI = 1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1

...xaazatricyclo[22.3.0.0^9,13]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl}oxidanesulfonic acid ...63-87-39)27-7-9-29(10-8-27)49(75)58-34-20-38(70)52(78)62-54(80)45-46(72)25(2)23-65(45)56(82)43(37(69)22-41(57)71)60-53(79)44(48(74)47(73)30-13-16-36(68)

...ضبط أعراض السحب يبقى على جرعة ثابتة لمدة 3-5 أيام ثم تخفض بالتدريج على مدى 2-4 أسابيع. #العلاج بإعطاء مركب [[نالوكسون]] حقن وريدي بجرعة 2ملغ تكرر حسب الحاجة حتى جرعة كلية قصوى تعا

...ةُ الزُّحارِيَّةُ من النَّمَطُ الثَّانِي]] {{إنج|Shigella dysenteriae type 2}} '''المرادف''' [[شيغيلة شمتزية|الشِّيغِيلَّ ...الشِّيغِيلَّةُ المُتَغَيِّرَة]]<ref>[http://ebm.rsmjournals.com/content/53/2/129.extract '''Antigenic Relationships of the Species Shigella dispar''' Ex

...-13-(acetyloxy)-5,17-dihydroxy-2,6,10,11-tetramethyltetracyclo[8.7.0.0^2,7.0^11,15]heptadecan-14-ylidene]-6-methylhept-5-enoic acid ...C3/[C@@H]2C[C@@H](O)[C@H]1[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]1([C@]2(C[C@@H]3OC(=O)C)C)C)CC\C=C(/C)C

...اء ما يجعل من المحتمل أن أفعاله تنقل بواسطة أعصاب حسية من الأمعاء والكبد. [2] ...مع السمنة، أما فرط إفرازه فيترافق مع حصول هبوط في سكر الدم تالٍ للوجبات.[2]

...2-thienylacetyl)oxy]-9,9-dimethyl-<br />3-oxa-9-azoniatricyclo[3.3.1.0^2,4]nonane bromide | C=19 | H=22 | Br=1 | N=1 | O=4 | S=2

...'-1-benzopyran-2-yl)-2-{[2-(6-fluoro-3,4-dihydro-2''H''-1-benzopyran-2-yl)-2-hydroxyethyl]amino}ethan-1-ol | C=22 | H=25 | F=2 | N=1 | O=4

...= (''RS'')-2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4''H''-pyrazino[2,1-''a'']isoquinolin-4-one | C=19 | H=24 | N=2 | O=2

| IUPACName = (1''R'',2''R'',3''S'',4''S'',5''R'',6''S'')-cyclohexane-1,2,3,4,5,6-hexol | OtherNames =''cis''-1,2,3,5-''trans''-4,6-Cyclohexanehexol , Cyclohexanehexol,<br />Mouse antialope

| IUPAC_name = (''RS'')-''N,N''-dimethyl-1-(10''H''-phenothiazin-10-yl)propan-2-amine | C = 17 | H = 20 | N = 2 | S = 1

| C=19 | H=26 | N=2 | S=1 | StdInChI = 1S/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11

| InChI = 1/C10H21N3O/c1-4-12(5-2)10(14)13-8-6-11(3)7-9-13/h4-9H2,1-3H3 | StdInChI = 1S/C10H21N3O/c1-4-12(5-2)10(14)13-8-6-11(3)7-9-13/h4-9H2,1-3H3

| CAS_number = 115956-12-2 | C=19 | H=20 | N=2 | O=3

...1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydro-1''H''-indole-2-carboxylic acid | C=24 | H=34 | N=2 | O=5

| InChI = 1/C9H10O3/c1-2-12-9-5-7(6-10)3-4-8(9)11/h3-6,11H,2H2,1H3 | StdInChI = 1S/C9H10O3/c1-2-12-9-5-7(6-10)3-4-8(9)11/h3-6,11H,2H2,1H3

| IUPAC_name = (''RS'')-2-(hydroxymethyl)-4-{1-hydroxy-2-[6-(4-phenylbutoxy) hexylamino]ethyl}phenol ...-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2/t25-/m1/s1

| IUPAC_name = (''RS'')-''N''-Carbamoyl-2-phenyl-butanamide | C=11 | H=14 | N=2 | O=2

...اً دستورياً يصنف في الجدول A في معظم الدساتير العالمية ويجب أن يحتوي على 1.2% من ال[[ستركنين]]. يتمتع الستركنين بكميات ق # تحتوي الثمرة على عدة بذور(2-5) والتي تدعى بالخطأ باسم الجوز المقيء.

...انوز|المانوز]] بواسطة تفاعل "ووهل" Wohl الذي يسمح بازالة [[كربون|الكربون]] 2 من السلسلة الكربونية [[سكر|لسكر]] كحولدي.

<th>[[فلز قلوي ترابي|2]]</th> ...هيليوم</small><br />2<br /> <big>[[هيليوم|He]]</big><br /> <small>4.002602(2)</small></td>

| IUPAC_name = 7-bromo-5-(pyridin-2-yl)-1''H''-benzo[''e''][1,4]diazepin-2(3''H'')-one | CAS_number = 1812-30-2

| EINECS = 200-857-2 | StdInChI = 1S/C4H10/c1-4(2)3/h4H,1-3H3

| 2.5 | 2 - 5

| C=19 | H=24 | N=4 | O=2 | InChI = 1/C19H24N4O2/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,2

إذا كانت [[كتلة]] الجسم (200) جرام فإن قوة جذب الأرض له تساوي 2 نيوتن. أي أن وزنها = 2 نيوتن والجسم الذي كتلته (300) جرام فإن وزنه

...''S'')-((''S'')-1-((2''S'',3''S'')-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) 2-formamido-4-methylpentanoate | elimination_half-life = 1 to 2 hours

| IUPAC_name = 5-nitro-2-furaldehyde semicarbazone | InChI = 1/C6H6N4O4/c7-6(11)9-8-3-4-1-2-5(14-4)10(12)13/h1-3H,(H3,7,9,11)/b8-3+

| IUPAC_name = 2-[({4-[(1,3-thiazol-2-ylamino)sulfonyl]phenyl}amino)carbonyl]benzoic acid | C=17 | H=13 | N=3 | O=5 | S=2

2-(1H-imidazol-5-yl)ethyl imidothiocarbamate

| IUPAC_name = (''E'',''Z'')-2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-''N'',''N''-diethylethanamine | StdInChI = 1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23

...-1-ylmethylene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

...1,20,21,25-tetrahydroxy- 3,15-''bis''[(1''R'')-1-hydroxyethyl]- 26-methyl- 2,5,8,14,17,23-hexaoxo- 1,4,7,13,16,22-hexaazatricyclo [22.3.0.0<sup>9,13</su ...11-33)34-12-14-37(15-13-34)51(74)59-41-26-43(70)54(77)63-56(79)47-48(71)29(2)27-65(47)58(81)45(31(4)67)61-55(78)46(50(73)49(72)36-16-20-38(68)21-17-36)6

| IUPAC_name = (''RS'')-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone | elimination_half-life = 2.5–3 hours.

...'S'')-3-dibenzo[''b,e'']thiepin-11(6''H'')-ylidene-8-methyl-8-azabicyclo[3.2.1]octane | StdInChI = 1S/C22H23NS/c1-23-17-10-11-18(23)13-16(12-17)22-19-7-3-2-6-15(19)14-24-21-9-5-4-8-20(21)22/h2-9,17-18H,10-14H2,1H3

4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)- benzenesulfonamide

...rrolidin-1-ium-1-yl)-3,4,4a,4b,5,7,8,9,10,10b,11,12-dodecahydro-2H-naphtho[2,1-f]quinolin-1-ium;diiodide

| صورة2 = Gray1148.png

..._name = (13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline | InChI = 1/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3/t17-/m

| IUPAC_name = (2β,3α,5α,16β,17β)-3,17-bis(acetyloxy)-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)androstane dibromide | C=35 | H=62 | Br=2 | N=4 | O=4

(2R,6R,11R)- 6,11-dimethyl- 3-(2-phenylethyl)- 1,2,3,4,5,6-hexahydro- 2,6-methano- 3-benzazocin- 8-ol

...the abstract of {{Cite journal| issn = 0350-199X | volume = 51 | issue = 1–2 | pages = 47–50 | last = Hadzović | first = S | title = Pharmacy and the |2

...-2-(1-((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propylthio)methyl)cyclopropyl)acetic acid | elimination_half-life = 2.7-5.5 hours

...,14''S'',16''S'',17''R'')-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-[2-(propionyloxy)acetyl]-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3''H''-cy | elimination_half-life = 2.8 hours

| 2 | 4.002602(2)

| InChI = 1/C27H44O3/c1-17(2)25(29)13-8-18(3)23-11-12-24-20(7-6-14-27(23,24)5)9-10-21-15-22(28)16-26(30) | StdInChI = 1S/C27H44O3/c1-17(2)25(29)13-8-18(3)23-11-12-24-20(7-6-14-27(23,24)5)9-10-21-15-22(28)16-26(30)

| InChI = 1/C11H14O3/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7,12H,2-3,8H2,1H3 | StdInChI = 1S/C11H14O3/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7,12H,2-3,8H2,1H3

2-الوصف Description:

...-hexahydroxy -6-methyl-1,12-dioxo-1,4,4a,5,5a,6,12,12a-octahydrotetracene -2-carboxamide ...ChI = 1/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25,27-29,32-33H,1

| ImageFileL1 = Chlorobutanol Structural Formula V.2.svg | IUPACName = 1,1,1-Trichloro-2-methylpropan-2-ol

=3/2 kT [[جول]] = 3/2 eV) 0,039 = 300. (-5)**10. 8,6 = kT)

| IUPAC_name = endo-N-(8-methyl-8-azabicyclo[3.2.1]oct-3yl)-2,3-dihydro-3,3-dimethyl-indole-1-carboxamide

| IUPAC_name = 2-[(pyridin-3-ylcarbonyl)amino]ethyl nitrate | InChI = 1/C8H9N3O4/c12-8(7-2-1-3-9-6-7)10-4-5-15-11(13)14/h1-3,6H,4-5H2,(H,10,12)

| PIN = Diethyl benzene-1,2-dicarboxylate | InChI = 1/C12H14O4/c1-3-15-11(13)9-7-5-6-8-10(9)12(14)16-4-2/h5-8H,3-4H2,1-2H3

| ImageFile1 = Stearoyl-2-glycerol.png | ImageAlt1 = Structural formula of 2-glycerol monostearate

| StdInChI = 1S/C2H7N5/c3-1(4)7-2(5)6/h(H7,3,4,5,6,7) | C = 2

| IUPAC_name = 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine | C=9 | H=7 | Cl=2 | N=5

توجد مربعات سحرية مهما كان الحيز <math>n\ge1</math>، بإقصاء <math>n=2</math> (أربع أعداد)، مع كون الحالة <math>n=1</math> ت

| IUPAC_name = (''S'')-5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)<br />methylsulfinyl]-3''H''-benzoimidazole | InChI = 1/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19

...xolan-<br/>4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1''H''-1,2,4-triazol-5-one | C=35 | H=38 | Cl=2 | N=8 | O=4

| InChI = 1/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14) | StdInChI = 1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)

| IUPAC_name = 4-[2-(Dipropylamino)ethyl]-1,3-dihydro-2''H''-indol-2-one | C=16 | H=24 | N=2 | O=1

...'R'',3''R'',5''S'',6''R'')-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol | smiles = C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O

| IUPAC_name = (''E'')-5-([4-(2-carboxyethylcarbamoyl)phenyl]diazenyl)-2-hydroxybenzoic acid | CAS_number = 80573-04-2

| IUPAC_name = 4-[(1''R'')-2-(''tert''-butylamino)-1-hydroxyethyl]- 2-(hydroxymethyl)phenoll | InChI = 1/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3/t12-/m0/s1

| ImageFile = 2,6-bis(1,1-dimethylethyl)-4-methylphenol.svg | PIN = 2,6-Di-''tert''-butyl-4-methylphenol

| IUPAC_name = ''N''-[<nowiki />[4-(2-Dimethylaminoethoxy)phenyl]methyl]-3,4-dimethoxybenzamide | C=20 | H=26 | N=2 | O=4

| Formula = C₂HCl₃O ...b>Cl → Cl₃CCH(C₆H₄Cl)₂ + H₂O

| IUPAC_name = (1S)-5-(1-hydroxy-1-methylethyl)-2-methylcyclohex-2-en-1-ol | CAS_number = 42370-41-2

4-amino-N-pyridin-2-ylbenzenesulfonamide

...methyl- 3''H'',4<nowiki>'</nowiki>''H''-spiro [1-benzofuran- 2,1'-cyclohex[2]ene]- 3,4'-dione | InChI = 1/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1

| IUPAC_name = ''N''-Carbamoyl-2-phenyl-acetamide | C=9 | H=10 | N=2 | O=2

| elimination_half-life = 2–3 hours | CAS_number = 57-27-2

...methylpiperazin-1-yl)methyl]-''N''-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide ...13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)

| IUPAC_name = (2''S'')-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid | C=22 | H=22 | N=2 | O=4

| InChI = 1/C6H8O7.3K/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3 | StdInChI = 1S/C6H8O7.3K/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3

| IUPAC_name = 5-methyl-2-[(4-methyl-1''H''-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1''H''-pyrido[4,3-''b'']indol-1-one ...H18N4O/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2/h3-6,10H,7-9H2,1-2H3,(H,18,19)

...ركيز الدواء المضاد للعدوى وتأثيراته، ولكن يختص بتأثيره المضاد الحيوي أكثر.[2]

| IUPAC_name = (''RS'')-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate | C=20 | H=25 | Cl=1 | N=2 | O=5

2 – [[غضروف درقي]]<br /> (2) الرباط الحلقي الدرقي <br />

<td>[[فلز قلوى ترابي|'''2''']]</td>

<td>[[فلز قلوى ترابي|'''2''']]</td>

...C40H56/c1-31(19-13-21-33(3)25-27-37-35(5)23-15-29-39(37,7)8)17-11-12-18-32(2)20-14-22-34(4)26-28-38-36(6)24-16-30-40(38,9)10/h11-14,17-23,25-28,37H,15-1 ...C40H56/c1-31(19-13-21-33(3)25-27-37-35(5)23-15-29-39(37,7)8)17-11-12-18-32(2)20-14-22-34(4)26-28-38-36(6)24-16-30-40(38,9)10/h11-14,17-23,25-28,37H,15-1

| IUPAC_name = (3''Z'')-3-[1]benzofuro[3,2-''c''][1]benzoxepin-6(12''H'')-ylidene-''N,N''-dimethylpropan-1-amine | C=21 | H=21 | N=1 | O=2

| IUPAC_name = ''N''-&#x200b;[1-&#x200b;(1-&#x200b;benzothien-&#x200b;2-&#x200b;yl)&#x200b;ethyl]-&#x200b;''N''-&#x200b;hydroxyurea | elimination_half-life = 2.5 hours

...')-2-([(2''S'')-1-[(2''S'')-3-acetylsulfanyl-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino)-3-phenylpropanoic acid | C=20 | H=26 | N=2 | O=5 | S=1

| IUPAC_name = (''RS'')-5-[2-(''tert''-butylamino)-1-hydroxyethyl]benzene-1,3-diol | InChI = 1/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3

| IUPAC_name = (''RS'')-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5''H''-pyrrolo[3,4-''b'']pyrazin-5-yl 4-methylpiperaz | CAS_number = 43200-80-2

| IUPAC_name = 2-amino-7-isopropyl-5-oxo-5''H''-chromeno[2,3-''b'']pyridine-3-carboxylic acid | N=2 | O=4

...me = 9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4''H''-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid | InChI = 1/C19H17NO7/c1-3-5-9-16-10(13(21)7-12(18(23)24)20(16)4-2)6-11-14(22)8-15(19(25)26)27-17(9)11/h6-8H,3-5H2,1-2H3,(H,23,24)(H,25,26)

| IUPAC_name = Diphenyl(piperidin-2-yl)methanol | StdInChI = 1S/C18H21NO/c20-18(15-9-3-1-4-10-15,16-11-5-2-6-12-16)17-13-7-8-14-19-17/h1-6,9-12,17,19-20H,7-8,13-14H2

| IUPAC_name = (''S'')-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-''b''][1,3]thiazole | C=11 | H=12 | N=2 | S=1

...S'',11''S'',13''S'',14''S'',16''S'',17''R'')-9-fluoro- 11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahy | smiles = O=C(CO)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]/1(\C(=C/C(=O)\C=C\1)CC[C@H]4[C@@H]2C[C@@H]3C)C)C

| smiles = C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]\5[C@@]4([C@@H](C=C( ...-14-30-23-50-40-36(44-48)27(4)19-33(43(30,40)47)41(46)52-32-20-31(16-15-25(2)38(24)53-35-21-34(49-6)37(45)28(5)51-35)54-42(22-32)18-17-26(3)39(55-42)29-

| InChI = 1/C9H7NO/c11-8-5-1-3-7-4-2-6-10-9(7)8/h1-6,11H | StdInChI = 1S/C9H7NO/c11-8-5-1-3-7-4-2-6-10-9(7)8/h1-6,11H

| IUPAC_name = 2-{[(2''E'')-3-(3,4-dimethoxyphenyl)prop-2- enoyl]amino}benzoic acid

| IUPAC_name = 1,3-dimethyl-7H-purine-2,6-dione | C=7 | H=8 | N=4 | O=2

| IUPAC_name = diethyl [4-(1,3-benzothiazol-2-yl)benzyl]phosphonate | CAS_number = 75889-62-2

| OtherNames = 2-Cyanoethylamine{{Citation needed|date=June 2012}} | StdInChI = 1S/C3H6N2/c4-2-1-3-5/h1-2,4H2

| ImageFile1 = Ca(HPO4)(H2O)2 from JCS A Curry, N.A.; Jones, D.W. (1971.jpg | SMILES = O.O.OP(=O)([O-])[O-].[Ca+2]

| PIN = 7,9-Dihydro-1''H''-purine-2,6,8(3''H'')-trione{{حقيقة|date = October 2011}} | OtherNames = 2,6,8-Trioxypurine{{حقيقة|date = October 2011}}

| elimination_half-life = 2-4 hours | InChI = 1/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)

...ructures and relative stabilities | journal = J. Chem. Soc., Perkin Trans. 2 | year = 1989 | issue = 10 | pages = 1443–1447 | doi = 10.1039/P298900014 | C=14 | H=12 | Cl=1 | N=1 | O=2

| IUPACName = 2-Propylpentanamide<ref>{{cite web|title=dipropylacetamide - Compound Summary | EINECS = 219-394-2

| IUPAC_name = methyl&nbsp;''N''-(6-phenylsulfanyl-1''H''-benzoimidazol-<br>2-yl)carbamate | C=15 | H=13 | N=3 | O=2 | S=1

benzothiazole-2-sulfonamide | elimination_half-life = 2.5–5.5 hours

| IUPAC_name = (''S'')-1-[''N''-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile | elimination_half-life = 2 to 3 hours

| smiles = O=C(CO)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]/1(\C(=C/C(=O)\C=C\1)CC[C@H]4[C@@H]2C[C@H]3O)C)C ...21H27FO6/c1-18-6-5-12(24)7-11(18)3-4-13-14-8-15(25)21(28,17(27)10-23)19(14,2)9-16(26)20(13,18)22/h5-7,13-16,23,25-26,28H,3-4,8-10H2,1-2H3/t13-,14-,15+,1

| IUPAC_name = 8-Chloro-6-phenyl-<BR>4''H''-1,2,4-triazolo(4,3-''a'')-<BR>1,4-benzodiazepine | InChI = 1/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2

*ذورة التركيز: يصل للذروة في ال[[بلاسما]] بعد 1-2 ساعة من تناوله فموياً. #الأطفال (شهرين - 12 سنة): كهيدروكلوريد 0.5-2 ملغ/كغ - (12-18 سنة): 50-100 ملغ وتكرر الجرعة كل 4-

| IUPAC_name = 2-ethoxy-1-({4-[2-(2''H''-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1''H''-1,3-benzodiazole-7-carboxyli ...20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)

| InChI = 1/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8, | StdInChI = 1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,

| InChI = 1/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3 | StdInChI = 1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3

...-34)53(71)72-31(2)44(48(66)55-37)56-49(67)46-41(63)15-10-22-54-46;1-7-37(8-2)16-17-48(44,45)28-13-15-38-31(28)34(43)47-32(22(3)4)24(6)11-12-29(41)35-14- ...-34)53(71)72-31(2)44(48(66)55-37)56-49(67)46-41(63)15-10-22-54-46;1-7-37(8-2)16-17-48(44,45)28-13-15-38-31(28)34(43)47-32(22(3)4)24(6)11-12-29(41)35-14-

...]-7a-methyl-2,3,3a,5,6,7-hexahydro-<wbr>''1H''-inden-1-yl]-2-methyl-heptan-2-ol ...14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1

| IUPAC_name = (R*,S*)-2-(methylamino)-1-phenylpropan-1-ol | InChI = 1/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10-/m0/s1

...(10)5(11)6(12)13;5-4(1-6,2-7)3-8;;;/h2-5,7-11H,1H2,(H,12,13);6-8H,1-3,5H2;;2*1H2/q;;+3;;/p-3/t2-,3-,4+,5-;;;;/m1..../s1 1 أو 2 قرص مضغ أو ملعقة صغيرة 5 مل بعد ساعة واحدة

| IUPAC_name = methyl (5-benzoyl-1''H''-benzimidazol-2-yl)carbamate | bioavailability = 2-10%

|atomic mass= 95.96(2) |electrons per shell= 2, 8, 18, 13, 1

...بعد ذلك يسرب وريدياً بمعدل 1-4 ملغ/ د حيث يحل ضمن محلول ديكستروز 5% بتركيز 2غ/ 250 مل.

| IUPAC_name = 1,3-dinitrooxypropan-2-yl nitrate;<br>[3-(nitrooxy)-2-[(nitrooxy)methyl]propyl] nitrate | InChI = 1/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2

...= (2''E'')-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-''N'',''N''-diethylprop-2-enamide | StdInChI = 1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10

<td>[[فلز قلوي ترابي|'''2''']]</td> <td bgcolor="#a0ffa0"><font color="green">2</font><br />[[هيليوم|He]]</td>

...yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate | C=37 | H=48 | N=6 | O=5 | S=2

...(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,( ...(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,(

| IUPAC_name = (''RS'')-5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol | InChI = 1/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3

| InChI = 1/Ca.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2 | SMILES = [Ca+2].[O-]S([O-])(=O)=O

..._name = (1''S'',2''R'',4''R'')-''N'',2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine | CAS_number = 60-40-2

...,4]triazolo[4,3-''a'']pyrazin-7(8''H'')-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine ...في الولايات المتحدة تحت اسم '''جانوڤيا Januvia''' بواسطة شركة [[مرك]]. في 2 أبريل 2007، وافقت ادارة الغذاء والدواء على

*أكبر من 12 سنة: 2- 3 مكغ/كغ/اليوم أو 150 مكغ/اليوم. ...: نبدأ بجرعة 12.5 – 50 مكغ/اليوم، ثم نرفعها بمعدل 25- 50 مكغ/ اليوم بفواصل 2- 4 أسابيع، الجرعة المعتادة 100- 200 مكغ/اليوم.

| InChI = 1/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1 | StdInChI = 1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1

...oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid ...=O)O[C@H]4CC[C@@]3([C@H]5C(=O)/C=C2/[C@@H]1C[C@](C(=O)O)(C)CC[C@]1(C)CC[C@]2([C@@]5(CC[C@H]3C4(C)C)C)C)C

...ethyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylic acid | InChI = 1/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)3

| IUPAC_name = 2-[2-(azocan-1-yl)ethyl]guanidine | CAS_number = 645-43-2

| elimination_half-life = phase 1 = 4.5h,</br> phase 2 = 271h, </br> average = 33h | C=33 | H=40 | N=2 | O=9

| IUPAC_name = ''N,N,N<nowiki>'</nowiki>''-tris(2-hydroxyethyl)-''N'''-octadecylpropane-1,3-diamine dihydrofluoride ...15-16-17-19-28(22-25-30)20-18-21-29(23-26-31)24-27-32;;/h30-32H,2-27H2,1H3;2*1H

| InChI = 1/CH2O3.Mg/c2-1(3)4;/h(H2,2,3,4);/q;+2/p-2 | SMILES = [Mg+2].[O-]C([O-])=O

| IUPAC_name = 1,4:3,6-dianhydro-2,5-di-''O''-nitro-<small>D</small>-glucitol | CAS_number = 87-33-2

*'''الإجراءات عالية الخطورة''' يمكن إعطاء 2-3 جرعات أخرى قدر كل منها 1 غ كل 8 ساعات

...hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-1,2,3,4,4a,5,5a,6,12,12a-decahydrotetracene-1,3,12-trione | C=21 | H=21 | Cl=1 | N=2 | O=8

*هذا المستحضر شاد للمستقبلات الأدرينرجية 2β، [[موسع قصبي]]. يرخي هذا المحضر العضلات الملس القصبية بالتأثير الشاد للمستقبلات الادرينرجية 2 β مع تأثير طفيف على سرعة القلب.

| IUPAC_name = 6-piperidin-1-ylpyrimidine-2,4-diamine 3-oxide | elimination_half-life = 4.2 hours

| IUPACName = (5''Z'',8''Z'',11''Z'',14''Z'')-''N''-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide ...-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15-

| IUPAC_name = (''S'')-''N''-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide | elimination_half-life = 4.2–5.4 hours (shorter in children)

| IUPACName = 2-hydroxy-1,2,3-propane- tricarboxylic acid calcium salt (2:3) | SMILES = [Ca+2].[Ca+2].[Ca+2].O=C([O-])CC(O)(C([O-])=O)CC(=O)[O-].[O-]C(=O)C(O)(CC([O-])=O)CC([O-])=O

| InChI = 1/C7H6O2.Na/c8-7(9)6-4-2-1-3-5-6;/h1-5H,(H,8,9);/q;+1/p-1 | StdInChI = 1S/C7H6O2.Na/c8-7(9)6-4-2-1-3-5-6;/h1-5H,(H,8,9);/q;+1/p-1

| CAS_supplemental = <br /> {{CAS|80474-14-2}} (propionate) | smiles = O=C(SCF)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]/1(\C(=C/C(=O)\C=C\1)[C@@H](F)C[C@H]4[C@@H]2C[C@H]3C)

| IUPAC_name = (''RR'',''SS'')-5-(1-hydroxy-2-{[2-(4-hydroxyphenyl)-1-methylethyl]amino}ethyl)benzene-1,3-diol | CAS_number = 13392-18-2

...25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34)

[[ملف:Gray1163.png|تصغير|قطاع في المبيض، 1- الغطاء الخارجي، 1"- الحد الملاصق، 2- إستروما مركزية، 3- إستروما محيطية، 4- أوعي

| IUPAC_name = 1-(2-{[(4-chlorophenyl)methyl]sulfanyl}-2-(2,4-dichlorophenyl)ethyl)-1''H''-imidazole | C=18 | H=15 | Cl=3 | N=2 | S=1

<th>[[فلز قلوي ترابي|2]]</th> <td style="background:#c0ffff;"><font color="green">2</font><br /> [[هيليوم|He]]</td>

| IUPAC_name = 4-[(2''S'')-2-(3,5-Dioxopiperazin-1-yl)propyl]piperazine-2,6-dione ...= 1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)/t7-/m0/s1

! [[عناصر الدورة الثانية|'''2''']] * الكيمياء اللاعضوية (2)، منشورات جامعة دمشق.

| IUPAC_name = (''S'')-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8- tetrahydronaphthalen-1-ol ...-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3

| IUPAC_name = 2-(dibutylamino)-1-[(9''Z'')-2,7-dichloro-9-(4-chlorobenzylidene)-9''H''-fluoren-4-yl]ethanol | InChI = 1/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(

| IUPAC_name = (''S'')-''N''-Ethyl-1-[3-(trifluoromethyl)phenyl]-propan-2-amine | StdInChI = 1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3/t9-/m0/s1

| IUPAC_name = [17-(2'-Chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14, | smiles = ClCC(=O)[C@]3(OC(=O)CC)[C@]2(C[C@H](O)[C@]4(F)[C@@]/1(\C(=C/C(=O)\C=C\1)CC[C@H]4[C@@H]2C[C@@H]3C)C)C

...C_name = (±)-2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine | InChI = 1/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3

| IUPAC_name = 4-[(4-Chlorophenyl)-(5-fluoro-2-hydroxy-phenyl)-methylidene]aminobutanamide | C=17 | H=16 | Cl=1 | F=1 | N=2 | O=2

{| class="wikitable sortable" border="2" cellpadding="4" cellspacing="0" style="margin: 1em 1em 1em 0; background: ...} {{ref|3|3}} {{ref|4|4}} || 0.00008988 || 14.175 || 20.28 || 14.304 || 2.2

| IUPAC_name = 7-chloro-3-methyl-4''H''-1,2,4-benzothiadiazine 1,1-dioxide | C=8 | H=7 | Cl=1 | N=2 | O=2 | S=1

|IUPACName=calcium (2''R'',3''S'',4''R'',5''R'')- 2,3,4,5,6-pentahydroxyhexanoate ...c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/m11./s1

| CASNo1 = 39365-87-2 | SMILES = [O-][Si](=O)O[Si]([O-])([O-])O[Si](=O)[O-].[Mg+2].[Mg+2]

| InChI = 1/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H | StdInChI = 1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H

| IUPACName = Tris(2-hydroxyethyl)amine ...= {{Unbulleted list|Triethylolamine|2,2',2"-Trihydroxy-triethylamine|Tris(2-hydroxyethyl)amine|Trolamine|TEA|TEOA}}

|image name 2= |image name 2 comment=

* عمره النصفي في البلازما 1-2 ساعة

! وزن الجسم(كغ)!! المساحة القصوى التي يجوز تطبيق المحضر عليها (سم2) ...أ تأثيره المسكن بعد ساعة من تطبيقه ويصل لذروته خلال 2-3 ساعات ويدوم لمدة 1-2 ساعة بعد إزالة الرهيم.

| IUPAC_name = 3,5-diamino-6-chloro-''N''-(diaminomethylene)pyrazine-2-carboxamide | InChI = 1/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15)

| IUPAC_name = ''N''-benzyl-2-(2-nitro-1''H''-imidazol-1-yl)acetamide | StdInChI = 1S/C12H12N4O3/c17-11(14-8-10-4-2-1-3-5-10)9-15-7-6-13-12(15)16(18)19/h1-7H,8-9H2,(H,14,17)

...30)49-13-23(5)41;1-21-9-11-13(23-3)15(24-4)18(27-7)20(30-11)31-14-12(10-22-2)29-19(28-8)17(26-6)16(14)25-5/h19-44H,9-18H2,1-8H3;11-20H,9-10H2,1-8H3/t19? ...30)49-13-23(5)41;1-21-9-11-13(23-3)15(24-4)18(27-7)20(30-11)31-14-12(10-22-2)29-19(28-8)17(26-6)16(14)25-5/h19-44H,9-18H2,1-8H3;11-20H,9-10H2,1-8H3/t19?

...''R'')-(6-methoxyquinolin-4-yl)((2''S'',4''S'',8''R'')- 8-vinylquinuclidin-2-yl)methanol | C=20 | H=24 | N=2 | O=2

| IUPACName = (5''R'')-[(1''S'')-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5''H'')-one | EINECS = 200-066-2

| IUPAC_name = 11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6''H''-pyrido[2,3-''b''][1,4]benzodiazepin-6-one | C=19 | H=21 | N=5 | O=2

...-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,2 ...-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,2

| C=12 | H=19 | N=2 | O=2 | StdInChI = 1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1

...R'',3a''R'',7a''S'')-1-[(2''R'')-6-hydroxy-6-methyl-heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1''H''- inden-4-ylidene]ethylidene]-4-methylidene-cycl | smiles = O[C@@H]3C(=C)/C(=CC=C1CCC[C@]2([C@H]1CC[C@@H]2[C@H](C)CCCC(O)(C)C)C)C[C@@H](O)C3

|colspan="2" style="background-color:#ffdead;" align="center" | إنتاج زوجي | colspan="2" | [[ملف:Pairproduction.png]]

| SMILES1 = Cc1c(c([nH]c1/C=C\2/C(=C(C(=O)N2)C=C)C)Cc3c(c(c([nH]3)/C=C\4/C(=C(C(=O)N4)C)C=C)C)CCC(=O)O)CCC( ...1-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-

| IUPAC_name = (''2RS'')-1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one | StdInChI = 1S/C17H25NO/c1-3-15-7-9-16(10-8-15)17(19)14(2)13-18-11-5-4-6-12-18/h7-10,14H,3-6,11-13H2,1-2H3

...clohexyloxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yloxy)tetrahydro-2''H''-pyran-3,4-diol | elimination_half-life = 2 to 3 hours

| CAS_number = 4759-48-2 | C=20 | H=28 | O=2

|image name 2= |image name 2 comment=

| IUPACName = 2-Hydroxybenzoic acid | InChI = 1/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10)

| CAS_number = 8064-90-2 ...6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h5-7H,4H2,1-3H3,(H4,15,16,17,18);2-6H,11H2,1H3,(H,12,13)

Docosahexaenoic (DHA) -2. 2-يخفف آلام ال[[مفاصل]], ويقويها.

...ي ال[[بنكرياس]] (كان يطلق عليها سابقًا خلايا F) والموجدة في جزر لانغرهانس (2). وهو جزء من عائلة ببتيدات تضم البببتيد YY. ...Y. Handbook of Physiology: The Gastrointestinal System II. Section VI, Vol 2, 1989.

| C=32 | H=41 | N=1 | O=2 | InChI = 1/C32H41NO2/c1-31(2,3) 26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33) 32(35,27-11-6-

| الصورة 2 = Cork Oak - Ain Draham.jpg | عرض الصورة 2 =

إذن: n − a + f = 2

(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

| IUPAC_name = ''N''-{1-[2-(1''H''-indol-3-yl)ethyl]piperidin-4-yl}benzamide | CAS_number = 26844-12-2

| IUPAC_name = 2,2’,2’’-[benzene-1,2,3-triyltris(oxy)]tris(N,N,N-triethylethanaminium) triiodide | CAS_number = 65-29-2

| IUPAC_name = (1''S'',2''S'')-2-amino-1-phenylpropan-1-ol | StdInChI = 1S/C9H13NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7,9,11H,10H2,1H3/t7-,9+/m0/s1

| IUPAC_name = 2-[(Aminocarbonyl)oxy]-''N'',''N'',''N''-trimethylethanaminium chloride | CAS_number = 51-83-2

:<math>R(x)=b_{n-1}x^{n-1}+b_{n-2}x^{n-2}+\cdots+b_1x+b_0</math> 2. نمرر المعامل الواقع تماما إلى اليسار (''a''

| IUPAC_name = (''RS'')-3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | C=18 | H=19 | Cl=2 | N=1 | O=4

| IUPAC_name = (2''E'',4''S'',4a''R'',5aS,12a''R'')- 2-(amino-hydroxy-methylidene)- 4,7-bis(dimethylamino)- 10,11,12a-trihydroxy-4 | smiles = CN(C)[C@@H]1C(\O)=C(\C(N)=O)C(=O)[C@@]2(O)C(/O)=C3/C(=O)c4c(O)ccc(c4C[C@H]3C[C@@H]12)N(C)C

*فيروس نظير النزلة الوافدة البشري 2. *Rubulavirus، والذي يضم فيروس نظير النزلة الوافدة البشري 2 و فيروس نظير النزلة الوافدة البشري 4.

xylo-Pentane-1,2,3,4,5-pentol [87-99-0]

2-نبدأ الترقيم من الجهة أقرب للتفرع. Metha, 2-Etha, 3- Propa, 4- Buta, 5- penta, 6- Hexa, 7- Hepta, 8- Octa, 9- Nona, 10-

|electron configuration= &#91;[[argon|Ar]]&#93; 3d¹⁰ 4s² 4p⁴ |electrons per shell= 2, 8, 18, 6

\int_{0}^2 x \cos(x^2+1) \,dx باستخدام التعويض ''u'' = ''x''² + 1, نحصل على ''du'' = 2''x'' ''dx'' و

| IUPAC_name = 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-<br>1,3-thiazole-5-carboxylic acid | C=16 | H=16 | N=2 | Na= | O=3 | S=1

| IUPACName = 2,2-Bis(hydroxymethyl)1,3-propanediol

|IUPACName=1-Methyl-2-[(''E'')-2-(2-thienyl)vinyl]-5,6-dihydro-4''H''-pyrimidine | Formula=C₁₁H₁₄N₂S

...-1-ylmethylene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

|IUPACName=Sodium 1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate |OtherNames= Aerosol OT; AOT; sodium bis(2-ethylhexyl) sulfosuccinate; docusate sodium

...y-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-2,7,9-triazabicyclo[4.3.0]nona-2,4,8,10-tetraene | InChI = 1/C16H18N4O3S/c1-9-7-17-12(10(2)14(9)23-4)8-24(21)16-18-11-5-6-13(22-3)19-15(11)20-16/h5-7H,8H2,1-4H3,(H,18

...'R'')-6-(aminomethyl)-3,4,5-trihydroxy-oxan-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide | elimination_half-life = 2-3 hours

| IUPAC_name = (''RS'')-2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide | C=19 | H=24 | N=2 | O=3

...'',4''S'',6''R'')-<br>4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl]oxy-<br>2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-<br>[4-(4-pyridin-3-ylimidazol- ...(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3

| InChI = 1/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3, | StdInChI = 1S/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3,

...C_name = 5,5′-(2-hydroxypropane-1,3-diyl)bis(oxy)bis(4-oxo-4''H''-chromene-2-carboxylic acid) ...3H16O11/c24-11(9-31-14-3-1-5-16-20(14)12(25)7-18(33-16)22(27)28)10-32-15-4-2-6-17-21(15)13(26)8-19(34-17)23(29)30/h1-8,11,24H,9-10H2,(H,27,28)(H,29,30)

| IUPAC_name = (8''S'')-7-[(2''S'')-2-{[(2''S'')-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid | C=22 | H=30 | N=2 | O=5 | S=2

| IUPAC_name = ''(S)''-2-amino-1-phenyl-1-propanone | InChI = 1/C9H11NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7H,10H2,1H3/t7-/m0/s1

| IUPAC_name = [2,3-dichloro-4-(2-thienylcarbonyl)phenoxy]acetic acid | C=13 | H=8 | Cl=2 | O=4 | S=1

...(3-chlorophenyl)piperazin-1-yl]propyl)-3-ethyl-4-(2-phenoxyethyl)-1''H''-1,2,4-triazol-5(4''H'')-one | elimination_half-life = • Nefazodone: 2–4 hours<ref name="SchatzbergNemeroff2017" /><br />• [[Hydroxynefazodone

2- العلاقة المكتشفة ما بين الصفر والواحد كأ

| InChI = 1/C15H21N3O/c1-11(5-3-7-16)18-14-10-13(19-2)9-12-6-4-8-17-15(12)14/h4,6,8-11,18H,3,5,7,16H2,1-2H3 | StdInChI = 1S/C15H21N3O/c1-11(5-3-7-16)18-14-10-13(19-2)9-12-6-4-8-17-15(12)14/h4,6,8-11,18H,3,5,7,16H2,1-2H3

...يليكون|سيليكا]] [[سيليكون|Si]][[أكسجين|O]]₂. عند ضغط يتراوح بين 2,5 و 5,5 كيلوبار، يصبح انصهار [[إنستاتايت|الإ

| IUPAC_name = (2''S'')-''N''-benzyl-''N''-methyl-1-phenylpropan-2-amine | StdInChI = 1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1

| IUPACName = ''(2S)''-2-amino-3- [4-(4-hydroxy-3-iodo-phenoxy)- 3,5-diiodo-phenyl]propanoic acid | InChI = 1/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H

| elimination_half-life = 1-2 months | InChI = 1/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1

*فيروس نظير النزلة الوافدة البشري 2. *Rubulavirus، والذي يضم فيروس نظير النزلة الوافدة البشري 2 و فيروس نظير النزلة الوافدة البشري 4.

...يثوكسي فينيل)-5-[2-(3,4-<br />ثنائي ميثوكسي فينيل)إيثيل-ميثيل-أمينو]<br />-2-(1-ميثيل إيثيل)نتريل البنتان | C=27 | H=38 | N=2 | O=4